The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Celgene; CovACE Nanotechnology; crispr therapeutics; EUSA Pharma; Kite/Gilead; WUGEN, Inc.
Research Funding - Amgen; Kite, a Gilead company
Impact of age, prior therapies, and subsequent transplant on long-term outcomes of adults with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3.
 
Bijal D. Shah
Honoraria - BeiGene; Gilead Sciences; Pharmacyclics/Janssen; Spectrum/Acrotech
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Autolus; Bristol-Myers Squibb/Celgene; Century Therapeutics; Deciphera; Jazz Pharmaceuticals; Kite, a Gilead company; Lilly; Novartis; Pepromene; Pfizer; Pfizer; Precision Biosciences
Research Funding - Incyte; Jazz Pharmaceuticals (Inst); Kite/Gilead (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Janssen; Kite, a Gilead company; Novartis; Pfizer; Seagen; Stemline Therapeutics
 
Ryan Daniel Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene
 
Jae H. Park
Consulting or Advisory Role - AstraZeneca; Kite, a Gilead Company; Novartis
Research Funding - Amgen; Genentech; Juno Therapeutics
 
Roch Houot
Honoraria - ADC Therapeutics; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Kite, a Gilead Company; MSD; Novartis
Consulting or Advisory Role - Kite, a Gilead Company
 
Olalekan O. Oluwole
Honoraria - Gilead Sciences; Pfizer
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Cargo; Caribou Biosciences; Curio Science; Epizyme; Gilead Sciences; Janssen; Kite, a Gilead Company; Nektar; Novartis; Pfizer; Syncopation Life Sciences; TG Therapeutics
Research Funding - Allogene Therapeutics (Inst); Daiichi Sankyo Pharmaceutical (Inst); Kite, a Gilead Company (Inst); Pfizer (Inst)
 
Aaron Logan
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Bristol-Myers Squibb; Pfizer; Takeda
Research Funding - Amgen; Astellas Pharma; Autolus; Kadmon; Kite, a Gilead Company; Pharmacyclics; Talaris
Other Relationship - SERVIER
 
Nicolas Boissel
Honoraria - Amgen; ARIAD/Incyte; Astellas Pharma; Novartis; SERVIER
Consulting or Advisory Role - Amgen; Novartis; SERVIER
Research Funding - Amgen; Novartis
Expert Testimony - Amgen
 
Thibaut Leguay
Honoraria - Amgen; Incyte; Kite, a Gilead Company; SERVIER
Consulting or Advisory Role - Amgen; Incyte; SERVIER
 
Michael Russell Bishop
Honoraria - Bristol-Myers Squibb/Celgene/Juno; Incyte; Incyte; Sanofi/Aventis
Consulting or Advisory Role - Arcellx; Autolus; BMS; crispr therapeutics; Iovance Biotherapeutics; Kite, a Gilead company; Novartis; Sana Biotechnology
Speakers' Bureau - Agios; Bristol-Myers Squibb; Incyte; Kite, a Gilead company; Sanofi
Research Funding - Arcellx (Inst); crispr therapeutics (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Expert Testimony - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - BMS; Kite/Gilead; Novartis
 
Max S. Topp
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genmab; Kite, a Gilead Company; Roche; Takeda
Research Funding - Kite, a Gilead Company; Regeneron; Roche; Takeda
Travel, Accommodations, Expenses - Janssen; Kite, a Gilead Company
 
Kristen M. O'Dwyer
No Relationships to Disclose
 
Maria R. Baer
Research Funding - Abbvie (Inst); Ascentage Pharma (Inst); FORMA Therapeutics (Inst); Kite, a Gilead company (Inst); Kura Oncology (Inst); Takeda (Inst)
 
Gary J. Schiller
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Celgene; Incyte; Jazz Pharmaceuticals; Novartis; Ono Pharmaceutical
Speakers' Bureau - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Incyte; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Sanofi; Stemline Therapeutics
Research Funding - Abbvie; Actinium Pharmaceuticals; Actuate Therapeutics; Agios; Amgen; Arog; Astellas Pharma; AVM Biotechnology; Bristol-Myers Squibb/Celgene; Celator; Constellation Pharmaceuticals; Daiichi Sankyo; Deciphera; Delta-Fly Pharma; ElevateBio; FORMA Therapeutics; Fujifilm; Gamida Cell; Genentech/Roche; Geron; Incyte; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Mateon Therapeutics; Novartis; Onconova Therapeutics; Ono Pharmaceutical; Pfizer; PrECOG; REGiMMUNE; Samus Therapeutics; Sangamo Bioscience; Sanofi; Sellas Life Sciences; Stemline Therapeutics; Syros Pharmaceuticals; Takeda; Tolero Pharmaceuticals; Trovagene
 
Mehrdad Abedi
Honoraria - Abbvie; Bristol-Myers Squibb; Celgene; Kite, a Gilead Company
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Kite, a Gilead Company
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; Celgene; Kite, a Gilead Company
 
Monique C. Minnema
Consulting or Advisory Role - CDR-life (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst)
Speakers' Bureau - Celgene/Bristol-Myers Squibb (Inst); Janssen medical Affairs (Inst); Medscape (Inst)
Research Funding - BeiGene (Inst)
 
Patrick J. Stiff
Honoraria - Crispr Therapeutics; MorphoSys
Consulting or Advisory Role - Crispr Therapeutics; MorphoSys
Research Funding - Amgen; Cellectar; Gamida Cell; Gilead Sciences; Incyte; Karyopharm Therapeutics; Pfizer; Seagen
 
Lang Zhou
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Abbvie
 
Tsveta Hadjivassileva
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
 
Rita Damico Khalid
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Armin Ghobadi
No Relationships to Disclose